OrganiGram Historical Balance Sheet

OGI Stock

USD 1.52 0.01 0.66%

Trend analysis of OrganiGram Holdings balance sheet accounts such as Total Stockholder Equity of 202.3 M provides information on OrganiGram Holdings' total assets, liabilities, and equity, which is the actual value of OrganiGram Holdings to its prevalent stockholders. By breaking down trends over time using OrganiGram Holdings balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining OrganiGram Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether OrganiGram Holdings is a good buy for the upcoming year.

OrganiGram Holdings Inventory

56.52 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

About OrganiGram Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of OrganiGram Holdings at a specified time, usually calculated after every quarter, six months, or one year. OrganiGram Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of OrganiGram Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which OrganiGram currently owns. An asset can also be divided into two categories, current and non-current.

OrganiGram Holdings Balance Sheet Chart

As of now, OrganiGram Holdings' Other Stockholder Equity is increasing as compared to previous years. The OrganiGram Holdings' current Total Liabilities is estimated to increase to about 48.9 M, while Total Assets are projected to decrease to under 251.2 M.

Total Assets Total Current Liabilities Total Stockholder Equity Non Current Assets Total

Add Fundamental

Total Assets

Total assets refers to the total amount of OrganiGram Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in OrganiGram Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on OrganiGram Holdings balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of OrganiGram Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from OrganiGram Holdings' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into OrganiGram Holdings current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.As of now, OrganiGram Holdings' Other Stockholder Equity is increasing as compared to previous years. The OrganiGram Holdings' current Total Liabilities is estimated to increase to about 48.9 M, while Total Assets are projected to decrease to under 251.2 M.

	2021	2022	2023	2024 (projected)
Total Stockholder Equity	508.1M	271.6M	312.4M	202.3M
Total Current Liabilities	55.3M	22.4M	25.8M	18.3M

Total Stockholder Equity Total Current Liabilities

OrganiGram Holdings balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Property Plant And Equipment Net	Accounts Payable	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Common Stock	Short Long Term Debt Total	Net Tangible Assets	Long Term Debt	Short Term Investments	Long Term Debt Total
Total Assets		0.26	0.92	0.99	-0.26	-0.55	0.93	0.98	0.61	0.81	0.8	0.74	0.78	0.8	0.97	0.97	0.89	0.86	0.55	0.81	0.76	0.34	0.99	0.3	0.65	0.75
Other Current Liab	0.26		0.34	0.35	-0.85	-0.22	0.39	0.27	0.48	0.24	0.38	0.3	0.12	-0.16	0.23	0.13	0.39	0.13	-0.37	0.31	0.29	-0.59	0.31	-0.61	0.11	0.01
Total Current Liabilities	0.92	0.34		0.92	-0.32	-0.49	0.85	0.95	0.54	0.55	0.84	0.68	0.68	0.68	0.84	0.92	0.98	0.8	0.36	0.73	0.71	0.23	0.91	0.19	0.32	0.59
Total Stockholder Equity	0.99	0.35	0.92		-0.39	-0.61	0.92	0.98	0.69	0.78	0.85	0.77	0.77	0.7	0.95	0.94	0.89	0.87	0.42	0.82	0.81	0.2	0.99	0.16	0.63	0.68
Net Debt	-0.26	-0.85	-0.32	-0.39		0.52	-0.32	-0.3	-0.7	-0.15	-0.54	-0.47	-0.26	0.3	-0.21	-0.14	-0.35	-0.3	0.57	-0.29	-0.51	0.79	-0.37	0.81	-0.12	0.09
Retained Earnings	-0.55	-0.22	-0.49	-0.61	0.52		-0.49	-0.53	-0.68	-0.3	-0.85	-0.94	-0.86	-0.15	-0.55	-0.45	-0.5	-0.85	0.14	-0.69	-0.94	0.23	-0.64	0.26	-0.39	-0.41
Cash	0.93	0.39	0.85	0.92	-0.32	-0.49		0.87	0.57	0.82	0.75	0.7	0.77	0.77	0.96	0.84	0.85	0.75	0.55	0.77	0.7	0.32	0.91	0.28	0.62	0.85
Non Current Assets Total	0.98	0.27	0.95	0.98	-0.3	-0.53	0.87		0.63	0.74	0.83	0.71	0.72	0.74	0.91	0.98	0.9	0.85	0.46	0.75	0.76	0.27	0.98	0.23	0.57	0.63
Non Currrent Assets Other	0.61	0.48	0.54	0.69	-0.7	-0.68	0.57	0.63		0.5	0.72	0.66	0.53	0.11	0.54	0.51	0.47	0.6	-0.14	0.57	0.71	-0.35	0.67	-0.38	0.48	0.24
Cash And Short Term Investments	0.81	0.24	0.55	0.78	-0.15	-0.3	0.82	0.74	0.5		0.46	0.5	0.58	0.75	0.85	0.74	0.5	0.58	0.66	0.62	0.52	0.38	0.78	0.35	0.93	0.73
Net Receivables	0.8	0.38	0.84	0.85	-0.54	-0.85	0.75	0.83	0.72	0.46		0.94	0.87	0.42	0.74	0.76	0.83	0.92	0.05	0.77	0.95	-0.07	0.86	-0.11	0.37	0.51
Common Stock Shares Outstanding	0.74	0.3	0.68	0.77	-0.47	-0.94	0.7	0.71	0.66	0.5	0.94		0.95	0.41	0.74	0.66	0.69	0.95	0.09	0.82	0.99	-0.04	0.81	-0.08	0.51	0.59
Other Stockholder Equity	0.78	0.12	0.68	0.77	-0.26	-0.86	0.77	0.72	0.53	0.58	0.87	0.95		0.6	0.82	0.7	0.69	0.94	0.33	0.8	0.93	0.22	0.82	0.18	0.56	0.78
Total Liab	0.8	-0.16	0.68	0.7	0.3	-0.15	0.77	0.74	0.11	0.75	0.42	0.41	0.6		0.83	0.83	0.66	0.6	0.91	0.55	0.4	0.81	0.72	0.78	0.57	0.84
Total Current Assets	0.97	0.23	0.84	0.95	-0.21	-0.55	0.96	0.91	0.54	0.85	0.74	0.74	0.82	0.83		0.9	0.83	0.84	0.62	0.84	0.75	0.4	0.95	0.36	0.72	0.86
Property Plant And Equipment Net	0.97	0.13	0.92	0.94	-0.14	-0.45	0.84	0.98	0.51	0.74	0.76	0.66	0.7	0.83	0.9		0.87	0.83	0.57	0.7	0.69	0.4	0.95	0.37	0.57	0.64
Accounts Payable	0.89	0.39	0.98	0.89	-0.35	-0.5	0.85	0.9	0.47	0.5	0.83	0.69	0.69	0.66	0.83	0.87		0.78	0.33	0.74	0.7	0.2	0.88	0.16	0.26	0.6
Common Stock Total Equity	0.86	0.13	0.8	0.87	-0.3	-0.85	0.75	0.85	0.6	0.58	0.92	0.95	0.94	0.6	0.84	0.83	0.78		0.29	0.83	0.96	0.16	0.91	0.12	0.56	0.64
Non Current Liabilities Total	0.55	-0.37	0.36	0.42	0.57	0.14	0.55	0.46	-0.14	0.66	0.05	0.09	0.33	0.91	0.62	0.57	0.33	0.29		0.32	0.07	0.93	0.43	0.92	0.54	0.76
Property Plant And Equipment Gross	0.81	0.31	0.73	0.82	-0.29	-0.69	0.77	0.75	0.57	0.62	0.77	0.82	0.8	0.55	0.84	0.7	0.74	0.83	0.32		0.78	0.18	0.82	0.14	0.58	0.67
Common Stock	0.76	0.29	0.71	0.81	-0.51	-0.94	0.7	0.76	0.71	0.52	0.95	0.99	0.93	0.4	0.75	0.69	0.7	0.96	0.07	0.78		-0.08	0.84	-0.12	0.52	0.55
Short Long Term Debt Total	0.34	-0.59	0.23	0.2	0.79	0.23	0.32	0.27	-0.35	0.38	-0.07	-0.04	0.22	0.81	0.4	0.4	0.2	0.16	0.93	0.18	-0.08		0.21	1.0	0.28	0.63
Net Tangible Assets	0.99	0.31	0.91	0.99	-0.37	-0.64	0.91	0.98	0.67	0.78	0.86	0.81	0.82	0.72	0.95	0.95	0.88	0.91	0.43	0.82	0.84	0.21		0.17	0.65	0.69
Long Term Debt	0.3	-0.61	0.19	0.16	0.81	0.26	0.28	0.23	-0.38	0.35	-0.11	-0.08	0.18	0.78	0.36	0.37	0.16	0.12	0.92	0.14	-0.12	1.0	0.17		0.25	0.6
Short Term Investments	0.65	0.11	0.32	0.63	-0.12	-0.39	0.62	0.57	0.48	0.93	0.37	0.51	0.56	0.57	0.72	0.57	0.26	0.56	0.54	0.58	0.52	0.28	0.65	0.25		0.62
Long Term Debt Total	0.75	0.01	0.59	0.68	0.09	-0.41	0.85	0.63	0.24	0.73	0.51	0.59	0.78	0.84	0.86	0.64	0.6	0.64	0.76	0.67	0.55	0.63	0.69	0.6	0.62

Click cells to compare fundamentals

OrganiGram Holdings Account Relationship Matchups

OrganiGram Holdings balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	417.6M	554.0M	577.1M	298.5M	343.2M	251.2M
Other Current Liab	(11.6M)	6.3M	12.0M	2.3M	2.6M	2.1M
Total Current Liabilities	29.1M	26.3M	55.3M	22.4M	25.8M	18.3M
Total Stockholder Equity	299.5M	479.8M	508.1M	271.6M	312.4M	202.3M
Net Debt	79.1M	(50.4M)	(65.2M)	(30.2M)	(27.1M)	(25.8M)
Retained Earnings	(144.9M)	(275.6M)	(289.9M)	(538.5M)	(484.7M)	(460.4M)
Cash	24.6M	55.4M	68.5M	33.9M	38.9M	27.4M
Non Current Assets Total	247.4M	293.4M	355.5M	142.5M	163.9M	144.2M
Non Currrent Assets Other	8.0M	31.1M	32.4M	19.1M	22.0M	12.7M
Cash And Short Term Investments	74.7M	183.8M	98.9M	33.9M	38.9M	58.5M
Net Receivables	17.0M	21.0M	43.9M	27.5M	31.6M	33.2M
Common Stock Shares Outstanding	43.2M	64.0M	77.2M	81.3M	93.5M	98.2M
Liabilities And Stockholders Equity	417.6M	554.0M	577.1M	298.5M	343.2M	251.2M
Other Stockholder Equity	23.7M	24.7M	28.3M	33.2M	38.2M	40.1M
Total Liab	118.1M	74.2M	69.0M	26.8M	30.9M	48.9M
Total Current Assets	170.2M	260.6M	221.6M	156.0M	179.4M	119.0M
Property Plant And Equipment Net	247.4M	235.9M	259.8M	99.0M	113.9M	135.1M
Accounts Payable	17.5M	19.0M	40.9M	20.0M	23.0M	15.8M
Non Current Liabilities Total	89.0M	47.9M	13.8M	4.4M	5.1M	4.8M
Accumulated Other Comprehensive Income	23.8M	24.6M	28.3M	33.2M	38.2M	40.1M
Common Stock	420.7M	730.8M	769.7M	776.9M	893.4M	938.1M
Short Long Term Debt Total	103.7M	5.0M	3.4M	3.7M	3.3M	3.2M
Other Liab	231K	43.1M	11.4M	771K	886.7K	842.3K
Net Tangible Assets	297.8M	462.8M	451.8M	261.0M	300.1M	258.4M
Other Assets	8.7M	35.4M	33.1M	1.0	1.15	1.09
Long Term Debt	46.1M	103.7M	230K	155K	178.3K	169.3K
Short Term Investments	380K	50.1M	128.5M	30.4M	35.0M	46.6M
Inventory	71.8M	48.8M	68.3M	81.0M	93.1M	56.5M
Other Current Assets	6.7M	7.0M	10.6M	13.7M	15.8M	10.0M
Deferred Long Term Liab	698K	7K	30K	391K	449.7K	354.3K
Long Term Investments	11.1M	7.0M	6.1M	7.1M	8.1M	4.3M
Short Long Term Debt	421K	3.5M	11.6M	80K	92K	87.4K
Short Term Debt	11.6M	1.1M	996K	76K	87.4K	83.0K
Intangible Assets	1.8M	2.7M	14.3M	10.6M	12.2M	12.8M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:

How To Invest In OrganiGram

Details

Is OrganiGram Stock a good investment?

Details

What is OrganiGram Holdings' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.80)

Revenue Per Share

1.835

Quarterly Revenue Growth

(0.14)

Return On Assets

(0.06)

Return On Equity

(0.55)

The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

OrganiGram Historical Balance Sheet

OrganiGram Holdings Inventory

56.52 Million

About OrganiGram Balance Sheet Analysis

OrganiGram Holdings Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Non Current Assets Total

OrganiGram Holdings balance sheet Correlations

OrganiGram Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

OrganiGram Holdings balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Total Stockholder Equity	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.98	Total Assets

Common Stock	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Other Stockholder Equity	- 0.86	Retained Earnings
Common Stock Total Equity	- 0.85	Retained Earnings
Net Receivables	- 0.85	Retained Earnings
Net Debt	- 0.85	Other Current Liab